Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy

Journal of Traditional and Complementary Medicine

Volumn 5, Issue 3, 2015, Pages 119-126

  Gnabre, John ^a   Bates, Robert ^b   Huang, Ru Chih ^c  

^a Mal 4 Research Institute   (United States)

^b University of Arizona   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cancer; creosote bush; lignans; nordihydroguaiaretic acid; viruses

Indexed keywords

EID: 84940162629     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2014.11.024     Document Type: Review

References (52)

1. Van der Crabben J. Medicine. In: Ancient History Encyclopedia; available at: www.ancient.eu.com/medicine Accessed 05.08.11.
2. G.B. Mahady Global harmonization of herbal health claims J Nutr 131 2001 1120S 1123S
3. H. Xu, M. Lv, and X. Tian A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007 Curr Med Chem 16 2009 327 349
4. I. Ionkova Anticancer lignans: from discovery to biotechnology Mini Rev Med Chem 11 2011 843 856
5. A. Panossian, and G. Wikman Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine J Ethnopharmacol 118 2008 183 212
6. S. Arteaga, A. Andrade-Cetto, and R. Cárdenas Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid J Ethnopharmacol 98 2005 231 239
7. V.V. Lia, V.A. Confalonieri, C.I. Comas, and J.H. Hunziker Molecular phylogeny of Larrea and its allies (Zygophyllaceae): reticulate evolution and the probable time of creosote bush arrival to North America Mol Phylogenet Evol 21 2001 309 320
8. R.G. Laport, R.L. Minckley, and J. Ramsey Phylogeny and Cytogeography of the North American Creosote Bush (Larrea tridentata, Zygophyllaceae) Systematic Botany 37 2012 153 164
9. T.J. Mabry, J.H. Hunziker, and D.R. DiFeo Jr. Creosote Bush: Biology and Chemistry of Larrea in the New World Deserts 1977 Hutchinson and Ross, Inc. Stroudsburg, PA: Dowden
10. C. Konno, Z.Z. Lu, H.Z. Xue, and et al. Furanoid lignans from Larrea tridentata J Nat Prod 53 1990 396 406
11. R.D. Haworth Natural resins Ann Rep Prog Chem 33 1936 267 278
12. J. Zhang, J. Chen, Z. Liang, and C. Zhao New lignans and their biological activities Chem Biodivers 11 2014 1 54
13. D.W. Macrae, and N.G.H. Towers Biological activities of lignans Phytochemistry 23 1984 1207 1220
14. J.M. Lü, J. Nurko, S.M. Weakley, and et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update Med Sci Monit 16 2010 RA93 RA100
15. J.N. Gnabre, Y. Ito, Y. Ma, and R.C. Huang Isolation of anti-HIV-1 lignans from Larrea tridentata by counter-current chromatography J Chromatogr A 719 1996 353 364
16. D.E. Sok, H.S. Cui, and M.R. Kim Isolation and bioactivities of furfuran type lignan compounds from edible plants Recent Pat Food Nutr Agric 1 2009 87 95
17. J. Gnabre, I. Unlu, T.-C. Chang, and et al. Isolation of lignans from Schisandra chinensis with anti-proliferative activity in human colorectal carcinoma: structure-activity relationships J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 2693 2700
18. Y.J. Lee, Y.M. Lee, C.K. Lee, J.K. Jung, S.B. Han, and J.T. Hong Therapeutic applications of compounds in the Magnolia family Pharmacol Ther 130 2011 157 176
19. J.D. Lambert, R.T. Dorr, and B.N. Timmermann Nordihydroguaiaretic acid, a review of its numerous and varied biological activities Pharm Biol 42 2004 149 158
20. J.D. Lambert, D. Zhao, R.O. Meyers, R.K. Kuester, B.N. Timmermann, and R.T. Dorr Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse Toxicon 40 2002 1701 1708
21. J.N. Gnabre, J.N. Brady, D.J. Clanton, and et al. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans Proc Natl Acad Sci USA 92 1995 11239 11243
22. R.A. Lopez, A.B. Goodman, M. Rhodes, J.A. Blomberg, and J. Heller The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration Anticancer Drugs 18 2007 933 939
23. D.S. Ruelas, and W.C. Greene An integrated overview of HIV-1 latency Cell 155 2013 519 529
24. J.S. Smith, and N.J. Robinson Age-specific prevalence of infection with herpes simplex virus types 2 and1: a global review J Infect Dis 186 suppl 1 2002 S3 S28
25. F.J. Jenkins, and S.L. Turner Herpes simplex virus: a tool for neuroscientists Front Biosci 1 1996 d241 d247
26. H.H. Dalfour Jr. Antiviral drugs N Engl J Med 340 1999 1255 1268
27. J. Piret, and G. Guy Boivin Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management Antimicrob Agents Chemother 55 2011 459 572
28. H. Chen, L. Teng, J.N. Li, and et al. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA J Med Chem 41 1998 3001 3007
29. H. Shin, and A. Iwasaki Generating protective immunity against genital herpes Trends Immunol 34 2013 487 494
30. J. Craigo, M. Callahan, R.C. Huang, and A.L. DeLucia Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives Antivir Res 47 2000 19 28
31. N. Khanna, R. Dalby, M. Tan, S. Arnold, J. Stern, and N. Frazer Phase I/II clinical safety studies of terameprocol vaginal ointment Gynecol Oncol 107 2007 554 562
32. N. Khanna, R. Dalby, A. Connor, A. Church, J. Stern, and N. Frazer Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers Sex Transm Dis 35 2008 577 582
33. C.C. Chang, Y.C. Liang, A. Klutz, and et al. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel Cancer Chemother Pharmacol 58 2006 640 653
34. J.A. Dohm, M.H. Hsu, J.R. Hwu, and et al. Influence of ions, hydration, and the transcriptional inhibitor P4N on the conformations of the Sp1 binding site J Mol Biol 349 2005 731 744
35. R. Park, C.C. Chang, Y.C. Liang, and et al. Systemic treatment with Tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors Clin Cancer Res 11 2005 4601 4609
36. C.C. Chang, J.D. Heller, J. Kuo, and R.C. Huang Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression Proc Natl Acad Sci USA 101 2004 13239 13244
37. R.C. Huang, C.C. Chang, and D. Mold Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid Semin Oncol 33 2006 479 485
38. S.A. Grossman, X. Ye, D. Peereboom, and et al. Phase I study of terameprocol in patients with recurrent high-grade glioma Neuro Oncol 14 2012 511 517
39. A. Breier, L. Gibalova, M. Seres, M. Barancik, and Z. Sulova New insight into P-glycoprotein as a drug target Anticancer Agents Med Chem 13 2013 159 170
40. K.J. Bailey-Dell, B. Hassel, L.A. Doyle, and D.D. Ross Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene Biochim Biophys Acta 1520 2001 234 241
41. P. Anand, A.B. Kunnumakkara, C. Sundaram, and et al. Cancer is a preventable disease that requires major lifestyle changes Pharm Res 25 2008 2097 2116
42. D. Steinhilber, A.S. Fischer, J. Metzner, and et al. 5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis Front Pharmacol 1 2010 143
43. R. Noor, S. Mittal, and J. Iqbal Superoxide dismutase: applications and relevance to human diseases Med Sci Monit 8 2002 RA210 RA215
44. D. Eads, R. Hansen, A. Oyegunwa, and et al. Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines J Inflamm (Lond) 6 2009 2
45. J. Luo, T. Chuang, J. Cheung, and et al. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata) Eur J Pharmacol 346 1998 77 79
46. D. Pitocco, M. Tesauro, R. Alessandro, G. Ghirlanda, and C. Cardillo Oxidative stress in diabetes: implications for vascular and other complications Int J Mol Sci 14 2013 21525 21550
47. R.A. Miller, D.E. Harrison, C.M. Astle, and et al. An aging interventions testing program: study design and interim report Aging Cell 6 2007 565 575 Erratum in: Aging Cell. 2008;7:445
48. R. Strong, R.A. Miller, C.M. Astle, and et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice Aging Cell 7 2008 641 650
49. S. Heron, and E. Yarnell The safety of low-dose Larrea tridentata (DC) Coville (creosote bush or chaparral): a retrospective clinical study J Altern Complement Med 7 2001 175 185
50. C.R. Smart, H.H. Hogle, H. Vogel, A.D. Broom, and D. Bartholomey Clinical experience with nordihydroguaiaretic acid - 'chaparrel tea' in the treatment of cancer Rocky Mt Med J 67 1970 39 43
51. N.M. Sheikh, R.M. Philen, and L.A. Love Chaparral-associated hepatotoxicity Arch Intern Med 157 1997 913 919
52. G. Bongiovanni, J. Cantero, A. Eynard, and M. Goleniowski Organic extracts of Larrea divaricata Cav. induced apoptosis on tumoral MCF7 cells with an higher cytotoxicity than nordihydroguaiaretic acid or paclitaxel J Exp Ther Oncol 7 2008 1 7